Read + Share
Amedeo Smart
Independent Medical Education
Naficy A, Chugh Y, Tariq M, Hawksworth H, et al. Immune response and safety of the adjuvanted recombinant zoster vaccine in adults 50 years of age and older in India: A randomized phase 3 trial. Vaccine 2025;50:126819.PMID: 39923547
Email
LinkedIn
Privacy Policy